Abstract:Osteosarcoma (OS) is the most common type of primary bone tumor in children and adolescents and has been associated with a high degree of malignancy, early metastasis, rapid progression and poor prognosis. However, the use of adjuvant chemotherapy improves the prognosis of patients with OS. OS chemotherapy is based primarily on the use of adriamycin, cisplatin (DDP), methotrexate (MTX), ifosfamide (IFO), epirubicin (EPI) and other drugs. Previous studies have revealed that the survival rate for patients with OS appears to have plateaued: 5‑year survival rates remain close to 60%, even with the use of combined chemotherapy. The most limiting factors include complications and fatal toxicity associated with chemotherapy agents, particularly high‑dose MTX (HD‑MTX), for which high toxicity and great individual variation in responses have been observed. Docetaxel (TXT) is a representative member of the relatively recently developed taxane class of drugs, which function to inhibit OS cell proliferation and induce apoptosis. Recently, more clinical studies have reported that TXT combined with gemcitabine (GEM) is effective in the treatment of OS (relapse/refractory and progressive), providing evidence in support of potential novel treatment strategies for this patient population. However, there is still no global consensus on this type of chemotherapy approach. The present review summarizes current studies surrounding progress in the chemotherapeutic treatment of OS and discusses the advantages and potential feasibility of TXT+GEM in the treatment of OS.

Origin and Therapies of Osteosarcoma

Mechanisms of Resistance to Conventional Therapies for Osteosarcoma

From biology to personalized medicine: recent knowledge in Osteosarcoma

Current Status and Prospects of Clinical Treatment of Osteosarcoma

Current and future therapeutic approaches for osteosarcoma

Translational biology of osteosarcoma

Update on Osteosarcoma

Molecular Pathogenesis and Therapeutic Strategies of Human Osteosarcoma

Targeting Molecular Mechanisms Underlying Treatment Efficacy and Resistance in Osteosarcoma: A Review of Current and Future Strategies

Osteosarcoma and Metastasis

Osteosarcoma: a comprehensive review

Present Advances and Future Perspectives of Molecular Targeted Therapy for Osteosarcoma

Advances in molecular pathogenesis of osteosarcoma

Molecular targeted therapy of osteosarcoma and related clinical

Progress in the Chemotherapeutic Treatment of Osteosarcoma (Review)

Recent Advances in Nanoplatforms for the Treatment of Osteosarcoma

Current Status and Prospects of Targeted Therapy for Osteosarcoma

Novel Immunotherapies for Osteosarcoma

Advancing therapy for osteosarcoma

Unraveling molecular aberrations and pioneering therapeutic strategies in osteosarcoma

Tumor-Associated Macrophages in Osteosarcoma: From Mechanisms to Therapy